US64125C1099 - Common Stock - After market: 101.22 0 (0%)
Date | Firm | Action | Rating |
---|---|---|---|
2023-03-30 | Canaccord Genuity | Upgrade | Hold -> Buy |
2023-03-03 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
2023-02-07 | Cantor Fitzgerald | Reiterate | Overweight |
2023-02-07 | Mizuho | Maintains | Neutral |
2023-02-07 | RBC Capital | Maintains | Sector Perform |
2023-02-07 | Barclays | Maintains | Overweight |
2023-02-07 | Wedbush | Maintains | Outperform |
2023-02-07 | Wells Fargo | Maintains | Equal-Weight |
2023-02-07 | Piper Sandler | Maintains | Neutral |
2023-02-07 | Citigroup | Maintains | Buy |
2023-02-07 | HC Wainwright & Co. | Reiterate | Buy |
2023-02-03 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
2022-11-14 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
2022-11-03 | Raymond James | Maintains | Outperform |
2022-11-03 | JP Morgan | Maintains | Overweight |
2022-11-02 | Cantor Fitzgerald | Maintains | Overweight |
2022-11-02 | Mizuho | Maintains | Neutral |
2022-11-02 | RBC Capital | Maintains | Sector Perform |
2022-11-02 | SVB Leerink | Maintains | Market Perform |
2022-11-02 | Wells Fargo | Maintains | Equal-Weight |
2022-11-02 | Morgan Stanley | Maintains | Equal-Weight |
2022-11-02 | Piper Sandler | Maintains | Neutral |
2022-10-24 | Citigroup | Maintains | Buy |
2022-10-20 | Mizuho | Maintains | Neutral |
2022-10-11 | UBS | Initiate | Buy |
2022-09-26 | Wells Fargo | Initiate | Equal-Weight |
2022-08-08 | Mizuho | Maintains | Neutral |
2022-08-05 | Barclays | Maintains | Overweight |
2022-07-15 | Morgan Stanley | Maintains | Equal-Weight |
2022-04-12 | Barclays | Maintains | Overweight |
Find the competitors with the best analyst ratings on the USA